Thyroid disease

Hyperthyroidism in Danish Pregnant Women During a 20-Year Period

J Clin Endocrinol MetabPublished Register-based cohort study

Main finding · Treatment with ATDs in pregnancyResult — go to the resultAdjusted odds ratio 1.51 95% CI 1.30–1.74

Authors' conclusion

The use of ATDs in Danish pregnant women increased following the implementation of IF and then leveled out. Results comply with observations in the general Danish population and suggest that IF influences the occurrence of autoimmune hyperthyroidism in younger individuals.

Study context

Population
Danish pregnant women, nationwide register-based cohort (1997–2016); Danish National Birth Cohort (1997–2003) and North Denmark Region Pregnancy Cohort (2011–2015)
Exposure
After vs before mandatory iodine fortification
Outcome
Maternal use of ATDs in pregnancy and frequency of early pregnancy biochemical hyperthyroidism
Methodological detailsnationwide, 2 birth cohorts with biochemical data
  • Nationwide
  • 2 birth cohorts with biochemical data

Main finding

Treatment with ATDs in pregnancy

Adjusted odds ratio

1.51

95% CI 1.30–1.74

After IF (2001-2004)vs Baseline (1997-1999)
aOR 1.51 (95% CI 1.30–1.74)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeaOR (95% CI)
Treatment with ATDs, West Denmark (previously moderately iodine-deficient)After IF (2001-2004)vs Baseline (1997-1999)1.67 (1.36–2.04)
Treatment with ATDs, East Denmark (mildly deficient)After IF (2001-2004)vs Baseline (1997-1999)1.30 (1.06–1.60)

Treatment with antithyroid drugs (ATDs) at end of follow-up

Returned to baseline levels in both regions

Early pregnancy biochemical hyperthyroidism

No time-related difference observed

Original publication

Hyperthyroidism in Danish Pregnant Women During a 20-Year Period. J Clin Endocrinol Metab. Published 12 July 2023. doi:10.1210/clinem/dgad410

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.